当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析 - 现金流量表

昆药集团

(600422)

  

流通市值:108.93亿  总市值:108.93亿
流通股本:7.57亿   总股本:7.57亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,789,337,884.731,625,293,351.578,175,598,178.245,022,528,797.45
  收到的税费返还4,626,766.5611,535,774.6313,033,968.7511,758,715.4
  收到其他与经营活动有关的现金192,196,783.5470,260,953.62471,737,335.99289,992,456.93
  经营活动现金流入小计3,986,161,434.831,707,090,079.828,660,369,482.985,324,279,969.78
  购买商品、接受劳务支付的现金2,022,292,823.61,027,979,308.894,101,535,338.492,771,267,065.94
  支付给职工以及为职工支付的现金438,823,095.97265,473,815.55765,320,326.7511,247,553.77
  支付的各项税费332,396,668.65167,314,871.87746,339,508.07417,519,064.79
  支付其他与经营活动有关的现金973,817,890.26385,768,512.242,239,108,669.021,407,905,258.21
  经营活动现金流出小计3,767,330,478.481,846,536,508.557,852,303,842.285,107,938,942.71
  经营活动产生的现金流量净额218,830,956.35-139,446,428.73808,065,640.7216,341,027.07
二、投资活动产生的现金流量:
  收回投资收到的现金1,288,418,692.36622,379,748.73,139,812,168.962,284,396,451.89
  取得投资收益收到的现金5,302,749.062,799,839.6215,595,092.9512,213,540.55
  处置固定资产、无形资产和其他长期资产收回的现金净额1,120,845.541,047,619.3951,801.8631,577.45
  投资活动现金流入小计1,294,842,286.96626,227,207.713,155,459,063.772,296,641,569.89
  购建固定资产、无形资产和其他长期资产支付的现金26,325,967.7313,248,028.7379,431,061.4731,360,351.99
  投资支付的现金2,630,700,0001,656,700,0002,990,000,0002,370,000,000
  投资活动现金流出小计2,657,025,967.731,669,948,028.733,069,431,061.472,401,360,351.99
  投资活动产生的现金流量净额-1,362,183,680.77-1,043,720,821.0286,028,002.3-104,718,782.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金--800,000800,000
  其中:子公司吸收少数股东投资收到的现金--800,000800,000
  取得借款收到的现金1,253,539,493.46953,621,441.38777,423,490.64511,856,962.4
  收到其他与筹资活动有关的现金--2,098,453,119.99-
  筹资活动现金流入小计1,253,539,493.46953,621,441.382,876,676,610.63512,656,962.4
  偿还债务支付的现金348,496,701.7894,620,773.47842,630,880.37590,871,850.14
  分配股利、利润或偿付利息支付的现金22,152,893.169,950,596.42186,524,936.25171,740,681.19
  其中:子公司支付给少数股东的股利、利润--13,980,0003,200,000
  支付其他与筹资活动有关的现金729,282,140.27722,141,297.861,975,510,861.5622,817,139.04
  筹资活动现金流出小计1,099,931,735.21826,712,667.753,004,666,678.18785,429,670.37
  筹资活动产生的现金流量净额153,607,758.25126,908,773.63-127,990,067.55-272,772,707.97
四、汇率变动对现金及现金等价物的影响1,028,421.1235,093.62987,451.2-219,445.44
五、现金及现金等价物净增加额-988,716,545.05-1,056,223,382.5767,091,026.65-161,369,908.44
  加:期初现金及现金等价物余额2,133,924,411.772,133,924,411.771,366,833,385.121,365,937,403.37
  期末现金及现金等价物余额1,145,207,866.721,077,701,029.272,133,924,411.771,204,567,494.93
补充资料:
  净利润249,920,820.76-751,220,665.56-
  资产减值准备4,752,967.11-21,954,873.58-
  固定资产和投资性房地产折旧55,206,137.69-114,594,168.92-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧55,206,137.69-114,594,168.92-
  无形资产摊销28,142,459.46-59,884,434.52-
  长期待摊费用摊销3,872,144.43-10,337,851.93-
  处置固定资产、无形资产和其他长期资产的损失757.86--1,012,610.84-
  固定资产报废损失-496,561.76-54,302.23-
  公允价值变动损失-1,445,663.76--6,915,856.46-
  财务费用27,472,873.34-24,268,314.16-
  投资损失694,593.72--14,933,233.77-
  递延所得税-29,230,675.45-8,208,773.19-
  其中:递延所得税资产减少-27,995,899.32-10,843,564.16-
    递延所得税负债增加-1,234,776.13--2,634,790.97-
  存货的减少78,098,571.92-271,851,735.92-
  经营性应收项目的减少182,962,263.19-41,815,890.73-
  经营性应付项目的增加-400,859,574.05--543,890,861.21-
  不涉及现金收支的投资和筹资活动金额其他项目--756,147,365.29-
  现金的期末余额1,090,511,562.96-2,133,924,411.77-
  减:现金的期初余额2,133,924,411.77-1,366,833,385.12-
  加:现金等价物的期末余额54,696,303.76---
  现金及现金等价物的净增加额-988,716,545.05-767,091,026.65-
公告日期2025-08-162025-04-292025-03-122024-10-26
审计意见(境内)标准无保留意见
TOP↑